SCHEMBL4169092

SCHEMBL4169092

C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(S(C)(=O)=O)CC4)cc3OC)ncc2I)c1

nearest known ligand 0.85

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EGFR P00533 19/20 0.85
NUAK2 Q9H093 2/20 0.71
PLK4 O00444 1/20 0.71
GAK O14976 1/20 0.71
NUAK1 O60285 1/20 0.71
JAK2 O60674 1/20 0.71
FLT3 P36888 1/20 0.71
BLK P51451 1/20 0.71
BMX P51813 1/20 0.71
JAK3 P52333 1/20 0.71
CTSC P53634 1/20 0.71
PTK2 Q05397 1/20 0.71
BTK Q06187 1/20 0.71
ITK Q08881 1/20 0.71
ERBB4 Q15303 1/20 0.71
DCLK3 Q9C098 1/20 0.71
EML4 Q9HC35 1/20 0.71
EIF2AK4 Q9P2K8 1/20 0.71
ALK Q9UM73 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9945459 0.92 EGFR (0.86) EGFRNUAK2PLK4GAKNUAK1
SCHEMBL2724418 0.92 EGFR (1.00) EGFRNUAK2PLK4GAKNUAK1
SCHEMBL2723097 0.90 EGFR (1.00) EGFRNUAK2PLK4GAKNUAK1
SCHEMBL9946951 0.88 EGFR (0.75) EGFRNUAK2PLK4GAKNUAK1
SCHEMBL9946943 0.88 EGFR (0.85) EGFRNUAK2PLK4GAKNUAK1
SCHEMBL9945460 0.87 EGFR (0.83) EGFRNUAK2PLK4GAKNUAK1
SCHEMBL9893511 0.85 EGFR (1.00) EGFRNUAK2PLK4GAKNUAK1
SCHEMBL10064985 0.84 EGFR (0.81) EGFRNUAK2PLK4GAKNUAK1
SCHEMBL15130588 0.84 EGFR (0.85) EGFRNUAK2PLK4GAKNUAK1
SCHEMBL4177480 0.84 EGFR (1.00) EGFRNUAK2PLK4GAKNUAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012061299-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2012-05-10 WO disclosed